129 related articles for article (PubMed ID: 22711223)
1. Risk practices among aboriginal people who inject drugs in New South Wales, Australia.
Paquette D; McEwan M; Bryant J
AIDS Behav; 2013 Sep; 17(7):2467-73. PubMed ID: 22711223
[TBL] [Abstract][Full Text] [Related]
2. Use of health services for sexually transmitted and blood-borne viral infections by young Aboriginal people in New South Wales.
Ward J; Bryant J; Worth H; Hull P; Solar S; Bailey S
Aust J Prim Health; 2013; 19(1):81-6. PubMed ID: 22951105
[TBL] [Abstract][Full Text] [Related]
3. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
[TBL] [Abstract][Full Text] [Related]
4. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
Graham S; Maher L; Wand H; Doyle M; Iversen J
Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
[TBL] [Abstract][Full Text] [Related]
5. Assessment of risky injection practices associated with hepatitis B, hepatitis C, and human immunodeficiency virus and using the blood-borne virus transmission risk assessment questionnaire.
Reynolds GL; Fisher DG; Napper LE
J Addict Dis; 2012; 31(1):80-8. PubMed ID: 22356671
[TBL] [Abstract][Full Text] [Related]
6. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
[TBL] [Abstract][Full Text] [Related]
7. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
8. Use of respondent-driven sampling to enhance understanding of injecting networks: a study of people who inject drugs in Sydney, Australia.
Paquette DM; Bryant J; De Wit J
Int J Drug Policy; 2011 Jul; 22(4):267-73. PubMed ID: 21550790
[TBL] [Abstract][Full Text] [Related]
9. The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.
Day C; Degenhardt L; Gilmour S; Hall W
BMC Public Health; 2005 Aug; 5():84. PubMed ID: 16102177
[TBL] [Abstract][Full Text] [Related]
10. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
[TBL] [Abstract][Full Text] [Related]
11. Bug breakfast in the bulletin: sexually transmissible infections and bloodborne viruses in Aboriginal and Torres Strait Islander populations.
Thomas SL; Kalsi H; Graham S
N S W Public Health Bull; 2012 Jun; 23(3-4):92. PubMed ID: 22697107
[No Abstract] [Full Text] [Related]
12. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
13. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
Iversen J; Wand H; Gonnermann A; Maher L;
Int J Drug Policy; 2010 Nov; 21(6):471-6. PubMed ID: 20472417
[TBL] [Abstract][Full Text] [Related]
15. Guarding against an HIV epidemic within an Aboriginal community and cultural framework; lessons from NSW.
Ward J; Akre SP; Kaldor JM
N S W Public Health Bull; 2010; 21(3-4):78-82. PubMed ID: 20513306
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C viral infection and imprisonment among Aboriginal and Torres Strait Islander and non-Indigenous people who inject drugs.
Smirnov A; Kemp R; Ward J; Henderson S; Williams S; Dev A; Najman JM
Drug Alcohol Rev; 2018 Nov; 37(7):831-836. PubMed ID: 30009499
[TBL] [Abstract][Full Text] [Related]
17. The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual.
Gilchrist G; Swan D; Shaw A; Keding A; Towers S; Craine N; Munro A; Hughes E; Parrott S; Strang J; Taylor A; Watson J
Harm Reduct J; 2017 Mar; 14(1):14. PubMed ID: 28320406
[TBL] [Abstract][Full Text] [Related]
18. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
Sullivan LG
Med J Aust; 1999 Aug; 171(3):165-6. PubMed ID: 10474613
[No Abstract] [Full Text] [Related]
19. Syringe coverage in an Australian setting: does a high level of syringe coverage moderate syringe sharing behaviour?
Bryant J; Paquette D; Wilson H
AIDS Behav; 2012 Jul; 16(5):1156-63. PubMed ID: 21811845
[TBL] [Abstract][Full Text] [Related]
20. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
